- Home
- Publications
- Publication Search
- Publication Details
Title
Recent developments in myelodysplastic syndromes
Authors
Keywords
-
Journal
BLOOD
Volume 124, Issue 18, Pages 2793-2803
Publisher
American Society of Hematology
Online
2014-09-19
DOI
10.1182/blood-2014-04-522136
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Myelodysplastic syndromes: 2014 update on diagnosis, risk-stratification, and management
- (2014) Guillermo Garcia-Manero AMERICAN JOURNAL OF HEMATOLOGY
- An activin receptor IIA ligand trap promotes erythropoiesis resulting in a rapid induction of red blood cells and haemoglobin
- (2014) Soraya Carrancio et al. BRITISH JOURNAL OF HAEMATOLOGY
- Results of a randomized, double-blind study of romiplostim versus placebo in patients with low/intermediate-1-risk myelodysplastic syndrome and thrombocytopenia
- (2014) Aristoteles Giagounidis et al. CANCER
- Disparity in perceptions of disease characteristics, treatment effectiveness, and factors influencing treatment adherence between physicians and patients with myelodysplastic syndromes
- (2014) David P. Steensma et al. CANCER
- Trends in incidence, initial treatment and survival of myelodysplastic syndromes: A population-based study of 5144 patients diagnosed in the Netherlands from 2001 to 2010
- (2014) Avinash G. Dinmohamed et al. EUROPEAN JOURNAL OF CANCER
- Association of the type of 5q loss with complex karyotype, clonal evolution,TP53mutation status, and prognosis in acute myeloid leukemia and myelodysplastic syndrome
- (2014) Sarah Volkert et al. GENES CHROMOSOMES & CANCER
- Somatic mutations found in the healthy blood compartment of a 115-yr-old woman demonstrate oligoclonal hematopoiesis
- (2014) H. Holstege et al. GENOME RESEARCH
- p53 protein expression independently predicts outcome in patients with lower-risk myelodysplastic syndromes with del(5q)
- (2014) L. Saft et al. HAEMATOLOGICA
- Prolonged Administration of Azacitidine With or Without Entinostat for Myelodysplastic Syndrome and Acute Myeloid Leukemia With Myelodysplasia-Related Changes: Results of the US Leukemia Intergroup Trial E1905
- (2014) Thomas Prebet et al. JOURNAL OF CLINICAL ONCOLOGY
- Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia
- (2014) Liran I. Shlush et al. NATURE
- Validation of the revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes
- (2013) Asmita Mishra et al. AMERICAN JOURNAL OF HEMATOLOGY
- When is iron overload deleterious, and when and how should iron chelation therapy be administered in myelodysplastic syndromes?
- (2013) David P. Steensma et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet
- (2013) L. Malcovati et al. BLOOD
- STAT3 mutations indicate the presence of subclinical T-cell clones in a subset of aplastic anemia and myelodysplastic syndrome patients
- (2013) A. Jerez et al. BLOOD
- The genetic basis of myelodysplasia and its clinical relevance
- (2013) M. Cazzola et al. BLOOD
- How we treat lower-risk myelodysplastic syndromes
- (2013) P. Fenaux et al. BLOOD
- How we treat higher-risk myelodysplastic syndromes
- (2013) M. A. Sekeres et al. BLOOD
- Clinical and biological implications of driver mutations in myelodysplastic syndromes
- (2013) E. Papaemmanuil et al. BLOOD
- Phase I clinical trial of oral rigosertib in patients with myelodysplastic syndromes
- (2013) Rami S. Komrokji et al. BRITISH JOURNAL OF HAEMATOLOGY
- Response to lenalidomide in myelodysplastic syndromes with del(5q): influence of cytogenetics and mutations
- (2013) Mar Mallo et al. BRITISH JOURNAL OF HAEMATOLOGY
- TP53mutations in myelodysplastic syndrome are strongly correlated with aberrations of chromosome 5, and correlate with adverse prognosis
- (2013) Austin G. Kulasekararaj et al. BRITISH JOURNAL OF HAEMATOLOGY
- Reproducibility of the World Health Organization 2008 criteria for myelodysplastic syndromes
- (2013) L. Senent et al. HAEMATOLOGICA
- Role of Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem-Cell Transplantation in Older Patients With De Novo Myelodysplastic Syndromes: An International Collaborative Decision Analysis
- (2013) John Koreth et al. JOURNAL OF CLINICAL ONCOLOGY
- Signal transduction inhibitors in treatment of myelodysplastic syndromes
- (2013) Lohith Bachegowda et al. Journal of Hematology & Oncology
- Skewed X-inactivation patterns in ageing healthy and myelodysplastic haematopoiesis determined by a pyrosequencing based transcriptional clonality assay
- (2013) Maximilian Mossner et al. JOURNAL OF MEDICAL GENETICS
- Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms
- (2013) F Traina et al. LEUKEMIA
- NRAS mutations with low allele burden have independent prognostic significance for patients with lower risk myelodysplastic syndromes
- (2013) D M Murphy et al. LEUKEMIA
- Clonal diversity of recurrently mutated genes in myelodysplastic syndromes
- (2013) M J Walter et al. LEUKEMIA
- Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents
- (2013) H Yang et al. LEUKEMIA
- Landscape of genetic lesions in 944 patients with myelodysplastic syndromes
- (2013) T Haferlach et al. LEUKEMIA
- P-104 Outcomes by IPSS-R in lenalidomide-treated patients with IPSS low-/Int-1-risk MDS With del(5q) in MDS-003 and MDS-004: A retrospective analysis
- (2013) M. Sekeres et al. LEUKEMIA RESEARCH
- Comparison of 24-month outcomes in chelated and non-chelated lower-risk patients with myelodysplastic syndromes in a prospective registry
- (2013) Roger M. Lyons et al. LEUKEMIA RESEARCH
- (R)-2-Hydroxyglutarate Is Sufficient to Promote Leukemogenesis and Its Effects Are Reversible
- (2013) J.-A. Losman et al. SCIENCE
- Revised IPSS (IPSS-R) stratification and outcome of MDS patients treated with azacitidine
- (2012) Massimo Breccia et al. ANNALS OF HEMATOLOGY
- Revised International Prognostic Scoring System for Myelodysplastic Syndromes
- (2012) P. L. Greenberg et al. BLOOD
- Final results of the phase II study of rabbit anti-thymocyte globulin, ciclosporin, methylprednisone, and granulocyte colony-stimulating factor in patients with aplastic anaemia and myelodysplastic syndrome
- (2012) Tapan M. Kadia et al. BRITISH JOURNAL OF HAEMATOLOGY
- Incidence, survival and prevalence of myeloid malignancies in Europe
- (2012) O. Visser et al. EUROPEAN JOURNAL OF CANCER
- Combination strategies in myelodysplastic syndromes
- (2012) Moshe C. Ornstein et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Late effect of Atomic bomb radiation on myeloid disorders: leukemia and myelodysplastic syndromes
- (2012) Hideki Tsushima et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Validation of a Prognostic Model and the Impact of Mutations in Patients With Lower-Risk Myelodysplastic Syndromes
- (2012) Rafael Bejar et al. JOURNAL OF CLINICAL ONCOLOGY
- New Comprehensive Cytogenetic Scoring System for Primary Myelodysplastic Syndromes (MDS) and Oligoblastic Acute Myeloid Leukemia After MDS Derived From an International Database Merge
- (2012) Julie Schanz et al. JOURNAL OF CLINICAL ONCOLOGY
- Topography, Clinical, and Genomic Correlates of 5q Myeloid Malignancies Revisited
- (2012) Andres Jerez et al. JOURNAL OF CLINICAL ONCOLOGY
- Historical perspectives on myelodysplastic syndromes
- (2012) David P. Steensma LEUKEMIA RESEARCH
- Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis
- (2012) Lambert Busque et al. NATURE GENETICS
- Detectable clonal mosaicism and its relationship to aging and cancer
- (2012) Kevin B Jacobs et al. NATURE GENETICS
- Detectable clonal mosaicism from birth to old age and its relationship to cancer
- (2012) Cathy C Laurie et al. NATURE GENETICS
- TET2andDNMT3AMutations in Human T-Cell Lymphoma
- (2012) Lucile Couronné et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clonal Architecture of Secondary Acute Myeloid Leukemia
- (2012) Matthew J. Walter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
- (2012) Jay P. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dysplasia Has A Differential Diagnosis: Distinguishing Genuine Myelodysplastic Syndromes (MDS) From Mimics, Imitators, Copycats and Impostors
- (2012) David P. Steensma Current Hematologic Malignancy Reports
- Implications of discrepancy in morphologic diagnosis of myelodysplastic syndrome between referral and tertiary care centers
- (2011) K. Naqvi et al. BLOOD
- Incidence of the myelodysplastic syndromes using a novel claims-based algorithm: high number of uncaptured cases by cancer registries
- (2011) C. R. Cogle et al. BLOOD
- Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS
- (2011) S M Luger et al. BONE MARROW TRANSPLANTATION
- Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS)
- (2011) L. Malcovati et al. HAEMATOLOGICA
- Targeting Immune Dysregulation in Myelodysplastic Syndromes
- (2011) Matthew J. Olnes JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Coalesced Multicentric Analysis of 2,351 Patients With Myelodysplastic Syndromes Indicates an Underestimation of Poor-Risk Cytogenetics of Myelodysplastic Syndromes in the International Prognostic Scoring System
- (2011) Julie Schanz et al. JOURNAL OF CLINICAL ONCOLOGY
- Outcome of High-Risk Myelodysplastic Syndrome After Azacitidine Treatment Failure
- (2011) Thomas Prébet et al. JOURNAL OF CLINICAL ONCOLOGY
- TP53 Mutations in Low-Risk Myelodysplastic Syndromes With del(5q) Predict Disease Progression
- (2011) Martin Jädersten et al. JOURNAL OF CLINICAL ONCOLOGY
- Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial
- (2011) U Platzbecker et al. LEUKEMIA
- Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias
- (2011) R Itzykson et al. LEUKEMIA
- The successful remission induction by sorafenib and long-term complete remission in a FLT3-ITD-positive patient with a refractory acute erythroid leukemia and abnormal cytogenetics
- (2011) Masanori Mori et al. LEUKEMIA RESEARCH
- Frequent pathway mutations of splicing machinery in myelodysplasia
- (2011) Kenichi Yoshida et al. NATURE
- Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes
- (2011) Timothy A Graubert et al. NATURE GENETICS
- Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia
- (2011) Víctor Quesada et al. NATURE GENETICS
- SomaticSF3B1Mutation in Myelodysplasia with Ring Sideroblasts
- (2011) E. Papaemmanuil et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Effect of Point Mutations in Myelodysplastic Syndromes
- (2011) Rafael Bejar et al. NEW ENGLAND JOURNAL OF MEDICINE
- SF3B1and Other Novel Cancer Genes in Chronic Lymphocytic Leukemia
- (2011) Lili Wang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hematopoietic Growth Factors in Myelodysplastic Syndromes
- (2011) David P. Steensma SEMINARS IN ONCOLOGY
- Knockdown of Hspa9, a del(5q31.2) gene, results in a decrease in hematopoietic progenitors in mice
- (2010) T. H.- P. Chen et al. BLOOD
- Subcutaneous or intravenous administration of romiplostim in thrombocytopenic patients with lower risk myelodysplastic syndromes
- (2010) Mikkael A. Sekeres et al. CANCER
- The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate
- (2010) Patrick S. Ward et al. CANCER CELL
- The Epidemiology of Myelodysplastic Syndromes
- (2010) Mikkael A. Sekeres HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Phase I Combination Trial of Lenalidomide and Azacitidine in Patients With Higher-Risk Myelodysplastic Syndromes
- (2010) Mikkael A. Sekeres et al. JOURNAL OF CLINICAL ONCOLOGY
- Alemtuzumab Treatment of Intermediate-1 Myelodysplasia Patients Is Associated With Sustained Improvement in Blood Counts and Cytogenetic Remissions
- (2010) Elaine M. Sloand et al. JOURNAL OF CLINICAL ONCOLOGY
- Incidence and Clinical Complications of Myelodysplastic Syndromes Among United States Medicare Beneficiaries
- (2010) Stuart L. Goldberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunosuppressive Therapy for Patients With Myelodysplastic Syndrome: A Prospective Randomized Multicenter Phase III Trial Comparing Antithymocyte Globulin Plus Cyclosporine With Best Supportive Care—SAKK 33/99
- (2010) Jakob R. Passweg et al. JOURNAL OF CLINICAL ONCOLOGY
- Risk of Myelodysplastic Syndromes in People Exposed to Ionizing Radiation: A Retrospective Cohort Study of Nagasaki Atomic Bomb Survivors
- (2010) Masako Iwanaga et al. JOURNAL OF CLINICAL ONCOLOGY
- Epidemiological data on myelodysplastic syndrome patients under 50 years in a single center of Romania
- (2010) Radu Gologan LEUKEMIA RESEARCH
- Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2
- (2010) Myunggon Ko et al. NATURE
- Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes
- (2010) Gorica Nikoloski et al. NATURE GENETICS
- Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders
- (2010) Thomas Ernst et al. NATURE GENETICS
- DNMT3AMutations in Acute Myeloid Leukemia
- (2010) Timothy J. Ley et al. NEW ENGLAND JOURNAL OF MEDICINE
- The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
- (2009) J. W. Vardiman et al. BLOOD
- Mutations of polycomb-associated geneASXL1in myelodysplastic syndromes and chronic myelomonocytic leukaemia
- (2009) Véronique Gelsi-Boyer et al. BRITISH JOURNAL OF HAEMATOLOGY
- Progressive Chromatin Repression and Promoter Methylation of CTNNA1 Associated with Advanced Myeloid Malignancies
- (2009) Y. Ye et al. CANCER RESEARCH
- Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
- (2009) Pierre Fenaux et al. LANCET ONCOLOGY
- Accurate detection of uniparental disomy and microdeletions by SNP array analysis in myelodysplastic syndromes with normal cytogenetics
- (2009) S Heinrichs et al. LEUKEMIA
- Differences in the distribution of subtypes according to the WHO classification 2008 between Japanese and German patients with refractory anemia according to the FAB classification in myelodysplastic syndromes
- (2009) Akira Matsuda et al. LEUKEMIA RESEARCH
- Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
- (2009) Lenny Dang et al. NATURE
- Identification of miR-145 and miR-146a as mediators of the 5q– syndrome phenotype
- (2009) Daniel T Starczynowski et al. NATURE MEDICINE
- Myelodysplastic Syndromes
- (2009) Ayalew Tefferi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mutation inTET2in Myeloid Cancers
- (2009) François Delhommeau et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia Genome
- (2009) Elaine R. Mardis et al. NEW ENGLAND JOURNAL OF MEDICINE
- IDH1andIDH2Mutations in Gliomas
- (2009) Hai Yan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
- (2009) M. Tahiliani et al. SCIENCE
- Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System
- (2008) Hagop Kantarjian et al. CANCER
- Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts
- (2008) G. J. Mufti et al. HAEMATOLOGICA
- Characteristics of US Patients with Myelodysplastic Syndromes: Results of Six Cross-sectional Physician Surveys
- (2008) Mikkael A. Sekeres et al. JNCI-Journal of the National Cancer Institute
- Identification of RPS14 as a 5q- syndrome gene by RNA interference screen
- (2008) Benjamin L. Ebert et al. NATURE
- Common troublesome symptoms and their impact on quality of life in patients with myelodysplastic syndromes (MDS): Results of a large internet-based survey
- (2007) David P. Steensma et al. LEUKEMIA RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started